BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 13, 2018
View Archived Issues
Vyera initiates phase I study of TUR-006 as treatment for toxoplasmosis
Read More
FDA awards orphan drug status to Abeona's ABO-202
Read More
FDA grants priority review to migalastat NDA
Read More
Dare Bioscience obtains license to Strategic Science & Technologies' SST-6007
Read More
FDA approves Icon Bioscience's Dexycu for inflammation associated with cataract surgery
Read More
Inovio Pharmaceuticals and The Wistar Institute to jointly develop vaccines for TB and malaria
Read More
SGSH gene therapy shows biological activity in phase I/II MPS type III A trial
Read More
Shire's SHP-647 granted orphan drug status for Crohn's disease in pediatric population
Read More
Cancer Targeted Technology, Advanced Accelerator Applications enter CTT-1057 license agreement
Read More
First-in-human results presented for SBC-103 in children with MPS IIIB
Read More
Foundation Fighting Blindness to support development of ProQR's candidate for Usher syndrome 2A
Read More
Sirenas and BMS enter multitarget research collaboration
Read More
FDA approves Symdeko to treat underlying cause of cystic fibrosis
Read More
Opiant Pharmaceuticals announces plans for intranasal nalmefene
Read More
Audentes Therapeutics begins dosing in phase I/II VALENS study
Read More
Kadmon reports phase II data on KD-025 in IPF
Read More
Avid Bioservices and Oncologie enter agreement for PS-targeting program
Read More
WntResearch revises design of planned phase II study of Foxy-5
Read More
Clenbuterol improves muscle function in patients with late-onset Pompe disease
Read More
Nerviano Medical Sciences patents new choline kinase inhibitors
Read More
Shenzhen Targetrx Biotechnology divulges novel EGFR mutant inhibitors
Read More
Shionogi identifies new dopamine D3 receptor antagonists
Read More
EC approves Diurnal's Alkindi as replacement therapy for pediatric adrenal insufficiency
Read More
Cerecor to acquire Avadel's pediatric business
Read More
Beijing Jacobio Pharmaceuticals patents AURKA and FADK 1 inhibitors
Read More
MabVax Therapeutics reports interim data from phase I study of MVT-5873
Read More
CPCI discovers new triptolide derivatives for the treatment of cancer
Read More
Erytech expands eryaspase program into triple-negative breast cancer
Read More
Nipro and TC BioPharm collaborate to codevelop novel CAR-T product for cancer
Read More
Methylene blue can be used to block Plasmodium falciparum transmission
Read More
